Hip implants are touted as life-changing medical advancements designed to improve an individual’s quality of life. Unfortunately, in some cases patients suffer more pain and discomfort than expected from the devices. This is due to toxic poisoning from defective, metal on metal implants. It is commonly a result of Cobalt Chromium Toxicity. Thousands of hip replacement patients are discovering their hip implants are releasing cobalt and chromium particles into their bodies, whether or not they have symptoms.
Settlements continue for the following metal on metal hips:
Stryker Orthopaedics announced a Settlement Agreement on November 3, 2014. The Stryker Hip Settlement Program may provide compensation to eligible patients who underwent revision surgery, replacing their ABG II Modular Neck Hip Stems and/or Rejuvenate Modular Neck, before November 3, 2014. Additionally, patients who cannot undergo revision surgery are possibly entitled to compensation; if the procedure was contraindicated for the patient prior to November 3, 2014.
The Stryker Modular Hip Settlement registration requires patients implanted with a Rejuvenate Modular hip or an ABG II Modular hip to submit basic information, pursuant to a court order. The court-ordered process applies to individuals regardless of whether they filed a claim or lawsuit, whether or not they underwent a qualified revision surgery (implant was removed before November 3, 2014), and whether or not they have legal representation. The registration process ended as of December 19, 2014.
You are not required to join the Settlement Program if you registered. However, if you intend on enrolling and participating in the Settlement Program, registering with the Claims Processor is not the same as enrolling in the Settlement Program. You will need to complete and submit an enrollment claim form as part of the separate Enrollment Process if you want to enroll in the Settlement Program. The Enrollment Process opens on January 16, 2015 and ends on March 2, 2015.
DePuy Orthopedics announced on November 19, 2013 they were initiating a voluntary settlement program in an effort to resolve approximately 8,000 lawsuits filed against them from the recall of their DePuy ASR prosthetic hip. Under the program, individuals who underwent revision surgery of their DePuy ASR hip prior to August 31, 2013 will receive a “base award” of $250,000 to settle their claims against DePuy. The base offer can adjust downward for a variety of health factors including the plaintiff’s age, the plaintiff’s smoking history, the plaintiff’s weight, and the length of time the implant was present prior to removal.
Under the program, there is a separate fund available to provide adjustments upward for individuals who underwent two revision surgeries or complications following their revision surgery. The extent of upward adjustments is extremely complicated and is based on a variety of individual factors.
The settlement does not impact or affect your rights if you have not had your ASR hip revised. The unrevised cases will continue to go forward. Eligible individuals had until Sept. 30, 2014 to potentially claim $250,000 or more from the DePuy ASR Hip Settlement Program.
Wright Profemur and Conserve Plus
On September 15, 2014, approximately 800 claims regarding the Conserve hips were filed against Wright Medical Technology Inc. in the ongoing multidistrict litigation (MDL) in U.S. District Court, Northern District of Georgia (In re: Wright Medical Technology, Inc., Conserve Hip Implant Products Liability Litigation, MDL No. 2329). As trial proceeds, filings continue to grow on behalf of individuals who suffered painful injuries associated with the Conserve hips as well as the Profemur hip replacements. The injuries sustained from the Conserve metal-on-metal hips include early device failure, femoral neck fractures, and metallosis.
The Wright Profemur and Conserve Plus hip lawsuits allege the hips caused serious complications as a result of elevated levels of metal ions, like cobalt and chromium, released from the hips. Currently, the court has selected a case for the litigation’s first bellwether trial scheduled for March 2015.
Recent studies demonstrate patients implanted with the Wright Profemur and Conserve Plus hip replacement systems often experience early failure and femoral neck fractures. Specifically, both these devices are “metal on metal” hips and recently the subject of much controversy. Under certain conditions, metal on metal hips can release metal particles into the hip joint and surrounding tissue. When this occurs, patients may experience significant pain in the hip joint resulting from the body’s reaction to the metal particles released into the hip. This condition is known as “metallosis” and often results in permanent damage to the hip joint.
Approximately 2,000 cases are currently pending in the Biomet M2A Magnum Multidistrict Litgation (MDL) underway in the U.S. District Court for the Northern District of Indiana. On December 9th, court documents showed the cases were filed on behalf on claimants who allege complications such as metallosis, pseudotumors, and other adverse effects secondary to the metal on metal design of the implant.
The court granted approval for a proposed settlement of the Biomet M2A Magnum lawsuits at the start of the year. The settlement would resolve hundreds of cases if finalized. The settlement terms were announced on February 3, 2014. Under the settlement, if plaintiffs underwent revision surgery (removing the hip) after the Biomet was implanted for more than 180 days from the index (initial) surgery, they are potentially entitled to a base award of $200,000. Court documents indicate the Biomet settlement would need to be accepted by 90% of eligible plaintiffs in order to be accepted.
Our attorneys have extensive experience litigating defective hip cases. We can answer any questions regarding these settlements and offer free case consultations. We will focus on your case, so you can focus on yourself.